Zimmer Biomet Borrows €500 Million Through 2033 And $500 Million Through 2036
The orthopedic-products maker's new euro bonds pay 4.375% annually, while its dollar bonds carry a 5.850% rate.
Zimmer Biomet, which makes orthopedic products including knee and hip replacements, completed €500 million of bonds due in 2033 and $500 million due in 2036 on Thursday. The company said in its SEC filing that the new borrowing carries annual interest rates of 4.375% in euros and 5.850% in dollars.
Two Currencies, Different Payment Schedules
The euro sale delivered €498.0 million in net proceeds before expenses. Barclays, Citigroup, HSBC, Morgan Stanley and RBC represented the banks underwriting that offering.
Barclays, BofA Securities, J.P. Morgan, Mizuho and SMBC Nikko represented the dollar offering's underwriters. Zimmer Biomet signed the underwriting agreements on November 5; both sales closed Thursday.
Euro bondholders will receive interest once a year, starting November 12, 2027, and principal is due November 12, 2033. Dollar bondholders will receive interest every May 12 and November 12, beginning May 12, 2027, with principal due November 12, 2036.
Earlier Debt Still Comes Due
Zimmer Biomet's existing listed bonds mature in 2026, 2027 and 2032. The new issues add later repayment dates alongside those obligations.
Some underwriting banks or their affiliates may own the company's 2026 bonds or its 4.700% bonds maturing in 2027. If Zimmer Biomet uses offering proceeds to repay those bonds, those banks would receive a share proportionate to their holdings.
The borrower sells implants, surgical products and digital and robotic technologies, including the ROSA Robot. Its customers include surgeons, hospitals and ambulatory surgery centers. The Americas is its largest regional business, followed by Europe, Middle East and Africa, then Asia Pacific.
Bondholders Get A Control-Change Protection
A qualifying change-of-control event would require Zimmer Biomet to offer affected bondholders 101% of principal plus accrued, unpaid interest. That obligation applies unless the company redeems the affected series.
Zimmer Biomet can also repay either series early under its redemption terms. From August 12, 2033, for the euro bonds, and August 12, 2036, for the dollar bonds, it can redeem them at principal value plus accrued, unpaid interest.
Zimmer Biomet plans to list the euro bonds on the New York Stock Exchange. Its underwriting agreement calls for reasonable efforts to begin trading within 30 calendar days of November 5, subject to approval.
Sources
- 8-K Filing — ZIMMER BIOMET HOLDINGS, INC. (ZBH) — SEC EDGAR
- Exhibit d118853dex11.htm — ZIMMER BIOMET HOLDINGS, INC. 8-K exhibit — SEC EDGAR